971 related articles for article (PubMed ID: 33176693)
1. First patient management of COVID-19 in Changsha, China: a case report.
Zhou J; Cao Z; Wang W; Huang K; Zheng F; Xie Y; Jiang D; Zhou Z
BMC Infect Dis; 2020 Nov; 20(1):824. PubMed ID: 33176693
[TBL] [Abstract][Full Text] [Related]
2. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
Chen LD; Li H; Ye YM; Wu Z; Huang YP; Zhang WL; Lin L
BMC Infect Dis; 2020 Jul; 20(1):517. PubMed ID: 32677909
[TBL] [Abstract][Full Text] [Related]
3. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
4. Clinical Analysis of 25 COVID-19 Infections in Children.
Bai K; Liu W; Liu C; Fu Y; Hu J; Qin Y; Zhang Q; Chen H; Xu F; Li C
Pediatr Infect Dis J; 2020 Jul; 39(7):e100-e103. PubMed ID: 32520888
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting.
Davoodi L; Jafarpour H; Taghavi M; Razavi A
J Investig Med High Impact Case Rep; 2020; 8():2324709620931239. PubMed ID: 32493073
[TBL] [Abstract][Full Text] [Related]
6. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
Zhu F; Cao Y; Xu S; Zhou M
J Med Virol; 2020 Jun; 92(6):529-530. PubMed ID: 32160316
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
8. Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.
Lim J; Jeon S; Shin HY; Kim MJ; Seong YM; Lee WJ; Choe KW; Kang YM; Lee B; Park SJ
J Korean Med Sci; 2020 Feb; 35(6):e79. PubMed ID: 32056407
[TBL] [Abstract][Full Text] [Related]
9. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.
Chen Q; Quan B; Li X; Gao G; Zheng W; Zhang J; Zhang Z; Liu C; Li L; Wang C; Zhang G; Li J; Dai Y; Yang J; Han W
J Med Virol; 2020 Jun; 92(6):683-687. PubMed ID: 32162699
[TBL] [Abstract][Full Text] [Related]
10. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao B; Wang Y; Wen D; Liu W; Wang J; Fan G; Ruan L; Song B; Cai Y; Wei M; Li X; Xia J; Chen N; Xiang J; Yu T; Bai T; Xie X; Zhang L; Li C; Yuan Y; Chen H; Li H; Huang H; Tu S; Gong F; Liu Y; Wei Y; Dong C; Zhou F; Gu X; Xu J; Liu Z; Zhang Y; Li H; Shang L; Wang K; Li K; Zhou X; Dong X; Qu Z; Lu S; Hu X; Ruan S; Luo S; Wu J; Peng L; Cheng F; Pan L; Zou J; Jia C; Wang J; Liu X; Wang S; Wu X; Ge Q; He J; Zhan H; Qiu F; Guo L; Huang C; Jaki T; Hayden FG; Horby PW; Zhang D; Wang C
N Engl J Med; 2020 May; 382(19):1787-1799. PubMed ID: 32187464
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
[TBL] [Abstract][Full Text] [Related]
12. BET 1: Lopinavir-ritonavir and COVID-19.
Dolan D; Ingham J; Baombe J
Emerg Med J; 2020 Jul; 37(7):450-451. PubMed ID: 32616658
[No Abstract] [Full Text] [Related]
13. The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report.
Zhang P; Cai Z; Wu W; Peng L; Li Y; Chen C; Chen L; Li J; Cao M; Feng S; Jiang X; Yuan J; Liu Y; Yang L; Wang F
BMC Infect Dis; 2020 Apr; 20(1):317. PubMed ID: 32354369
[TBL] [Abstract][Full Text] [Related]
14. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study.
Wang B; Li D; Liu T; Wang H; Luo F; Liu Y
BMC Infect Dis; 2020 Oct; 20(1):723. PubMed ID: 33008327
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China.
Zhou J; Sun J; Cao Z; Wang W; Huang K; Zheng F; Xie Y; Jiang D; Zhou Z
Medicine (Baltimore); 2020 Aug; 99(34):e21824. PubMed ID: 32846825
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
